NCT04688554

Brief Summary

A number of studies from the literature suggest important behavioral, psychosocial, or radiologic changes occur following significant neurologic events or interventions such as stroke, neurosurgery, medications, radiation, systemic therapy, or injury. The purpose of this study is to describe these changes with advanced neurologic imaging and targeted neurologic and neuropsychiatric assessments. This is a non-interventional observational study of minimal risk to participants as there is no medical intervention. The results of this study will be used to inform patients, scientists, and society in the development of future treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 25, 2020

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

3.4 years

First QC Date

September 16, 2020

Last Update Submit

December 3, 2024

Conditions

Keywords

Stereotactic RadiosurgeryCingulotomyCapsulotomy

Outcome Measures

Primary Outcomes (3)

  • Describe changes in Obsessive Compulsive Disorder disease burden after stereotactic radiosurgery.

    Yale-Brown Obsessive Compulsive Scale questionnaire

    Every 3 months for 1 year or through study completion

  • Describe changes in Depression disease burden after stereotactic radiosurgery.

    Beck's Depression inventory

    Every 3 months for 1 year or through study completion

  • Describe changes in Pain disease burden after stereotactic radiosurgery.

    McGill Pain Scale

    Every 3 months for 1 year or through study completion

Secondary Outcomes (2)

  • Describe changes in cognition after stereotactic radiosurgery.

    Every 3 months for 1 year or through study completion

  • Describe changes in radiologic parameters after stereotactic radiosurgery.

    Every 6 months for 1 year or through study completion

Study Arms (4)

Refractory Obsessive Compulsive Disorder

fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical capsulotomy

Diagnostic Test: fMRI and DTIBehavioral: Behavioral questionnairesBehavioral: Disease-Specific Patient-Reported OutcomesBehavioral: Behavioral tests

Refractory Pain

fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy

Diagnostic Test: fMRI and DTIBehavioral: Behavioral questionnairesBehavioral: Disease-Specific Patient-Reported OutcomesBehavioral: Behavioral tests

Refractory Tremor

fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical thalamotomy

Diagnostic Test: fMRI and DTIBehavioral: Behavioral questionnairesBehavioral: Disease-Specific Patient-Reported OutcomesBehavioral: Behavioral tests

Refractory Depression

fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy

Diagnostic Test: fMRI and DTIBehavioral: Behavioral questionnairesBehavioral: Disease-Specific Patient-Reported OutcomesBehavioral: Behavioral tests

Interventions

fMRI and DTIDIAGNOSTIC_TEST

Neurologic imaging correlates

Refractory DepressionRefractory Obsessive Compulsive DisorderRefractory PainRefractory Tremor

RAND 36-item Quality of Life survey, Mini Mental Status Exam, MOCA Cognitive Exam

Refractory DepressionRefractory Obsessive Compulsive DisorderRefractory PainRefractory Tremor

Y-BOCS Survey, QUEST, PDQ39, PHQ2 Depression Screening, PHQ9 Depression Inventory, Beck's Depression Inventory, PROMIS Pain Intensity Short Form 3, McGill Pain Scale, Visual Analog pain scale, FTM (Tremor Scale)

Refractory DepressionRefractory Obsessive Compulsive DisorderRefractory PainRefractory Tremor

Behavioral tests may include one or more of the following procedures: Upper extremity testing, Perdue Peg Board testing, Hand tactile detection and discrimination test, Temperature and pain threshold testing, Lower extremity Testing, Myomotion Inertial Motion Testing.

Refractory DepressionRefractory Obsessive Compulsive DisorderRefractory PainRefractory Tremor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

VUMC adult patients with neurologic disease or patients with neurologic interventions such as neurosurgical procedures or radiation therapy. Men and women of any ethnicity, race or socioeconomic status who meet inclusion criteria will be offered enrollment into the study. Patient will be greater than 18 years of age and meet inclusion and exclusion criteria. Patients eligible for this study will include patients with neurologic events, including but not limited to stroke, depression, infections, psychiatric disease. Intervention is not part of this study, however, patients receiving neurologic interventions, such as neurosurgical procedures or radiation therapy, would be eligible.

You may qualify if:

  • Age ≥ 18 years old and willing and able to sign a written informed consent.
  • Eligible for Brain MRI
  • History of neurologic event or intervention OR future planned neurologic intervention

You may not qualify if:

  • Contraindications to MRI of the brain
  • Patient declining participation in study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232-5671, United States

Location

MeSH Terms

Conditions

Obsessive-Compulsive DisorderPain, IntractableDepression

Interventions

Magnetic Resonance ImagingDiffusion Tensor ImagingBehavior Rating Scale

Condition Hierarchy (Ancestors)

Anxiety DisordersMental DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisNeuroimagingDiffusion Magnetic Resonance ImagingDiagnostic Techniques, NeurologicalInvestigative TechniquesPsychological TestsBehavioral Disciplines and Activities

Study Officials

  • Anthony J Cmelak, MD

    Vanderbilt University Medical Center

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Radiation Oncology

Study Record Dates

First Submitted

September 16, 2020

First Posted

December 30, 2020

Study Start

August 25, 2020

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Research data will be shared upon reasonable request to the principal investigator.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will become available after the publication of the study results.

Locations